$INND ROSEVILLE, CA. -- March 18, 2019 -- Investo
Post# of 231

ROSEVILLE, CA. -- March 18, 2019 -- InvestorsHub NewsWire -- InnerScope Hearing Technologies Inc. (OTCQB: INND) a manufacturer and Direct-to-Consumer ("DTC"


Matthew Moore, CEO of InnerScope commented, "InnerScope's continued record-setting growth is a result of successfully building a solid deep-rooted platform of Hearing Products with multiple sales channels through a strong foundation of various strategic and distribution partners, like Walmart.com."
Exponential Revenue Growth Strategy - Starting Second Quarter 2019 ("2019 Q2"

InnerScope's "Exponential Revenue Growth Strategy" is the culmination of developing unique innovative Hearing Products lined-up ready to go to market along with constant building of new possibilities of revenue streams through multiple partners and/or sales channels. InnerScope's believes it has not only built a scalable sales and marketing infrastructure but also a scalable Hearing Product platform whereby the newest innovative Hearing Products can be developed, marketed and sold through various vendor/retail sales channels. InnerScope's Exponential Revenue Growth Possibilities are:
Development and Release of New Self-Fitting Hearing Devices
Sold through and/or Distributed to:
Walmart.com (as a wholesale vendor)
Global Big Box Retailers
Multiple eCommerce Websites
Various Member Associations (as part of a hearing benefit for its members)
InnerScope anticipates its 2019 Q2 launch of the "NEXUS" by InnerScope, a Smartphone User Controlled Self-Fitting Hearing Aids ("NEXUS"

Development and Release of proprietary formulas of CDB Oil for Tinnitus and Doctor-Designed Nutritional Dietary Hearing Supplements
Sold through and/or Distributed to:
Global Big Box Retailers
Multiple eCommerce Websites
National Vitamins Retail Chains
InnerScope is planning on having its proprietary formulations of its CBD Oil for "Tinnitus" and its Doctor-Designed Nutritional Dietary Hearing Supplements ("Nutrition for the Ears"

FDA 510k Clinical Trial for the Treatment of Tinnitus using Low-Level Laser Therapy
- After receiving the FDA-510 Market Clearance
Marketed worldwide as the only FDA-Cleared Treatment for Tinnitus to date
Sold and administered through various medical professionals around the world
Marketed to the United States Veterans Administration ("VA"

InnerScope will be adding more approved clinical testing sites for its FDA-510 Clinical Trial of a doubleblind, placebo-controlled evaluation of the effect of using Low-Level Laser on the relief of Tinnitus symptoms. This will give InnerScope more data using a multi-site protocol. Tinnitus affects about 50 million people in the U.S. and 15% to 20% of the world's population suffers from Tinnitus. Moreover, 90% of people with Tinnitus also have hearing loss. Tinnitus is the most prevalent service-connected disability among Veterans. The VA alone is reported spending $3 billion dollars a year in Veteran claims related to Tinnitus and hearing loss.
New Audiological Clinic Expansion Roll-out Plan of Hearing Aid Retail Locations
Each new location is expected to generate a minimum of $500 thousand dollars to $1.5 million dollars in annual revenue.
InnerScope is continuing its Expansion Roll-out Plan with the expectation of opening 8 new Audiological Hearing Aid Retail Centers ("Retail Locations"

InnerScope's Product Portfolio of Direct-to-Consumer ("DTC"

Sold through and/or Distributed to:
Walmart.com (as a wholesale vendor)
Global Big Box Retailers
Multiple eCommerce Websites
Various Member Associations (as part of a hearing benefit for its members)
InnerScope is continuing to add and/or solicit major retailers for selling online or in-store its affordable high quality DTC FDA-Register Hearing Aids ("DTC Hearing Aids"


"With all of InnerScope's ongoing sales channels and the upcoming releases of the NEXUS and CBD Oil / Hearing Vitamins combined with opening more Audiological Hearing Aid Retail Locations, we are looking forward to the start 2019 Q2", said Matthew Moore, CEO of InnerScope Hearing Technologies. "I am very proud of InnerScope's team of individuals who has worked tirelessly over the past two years putting into place a scalable sales and distribution platform for our Hearing Products. By continuing to execute the business plans and strategy, we expect starting with 2019 Q2 and every quarter after, InnerScope has the ability to grow revenue exponentially quarter over quarter," concluded Mr. Moore.
About InnerScope Hearing Technologies ("INND"


